Synapse - Works

Results (2639)

Safety and efficacy of atezolizumab in combination with rituximab plus CHOP in previously untreated patients with diffuse large B-cell lymphoma (DLBCL): Updated analysis of a phase I/II study

Meeting Abstract

Younes, A.; Burke, J. M.; Cheson, B. D.; Diefenbach, C.; Ferrari, S.; Hahn, U. H.; Hawkes, E. A.; Khan, C.; Lossos, I. S.; Musuraca, G.; more...
Blood (2019)

Fulltext@MSK | Save

A multi-center dose-finding study to assess safety, tolerability, pharmacokinetics and preliminary efficacy of fimepinostat (CUDC-907) in combination with venetoclax in patients with relapsed/refractory (R/R) lymphoma

Meeting Abstract

Younes, A.; Batlevi, C. L.; Cohen, J. B.; de Vos, S.; Landsburg, D. J.; Myint, Z. W.; Patel, K.; Phillips, T. J.; Smith, S. M.; Westin, J. R.; more...
Blood (2019)

Fulltext@MSK | Save

Phase 1 dose-finding study investigating CA-4948, an IRAK4 kinase inhibitor, in patients with R/R NHL: Report of initial efficacy and updated safety information

Meeting Abstract

Younes, A.; Nowakowski, G.; Rosenthal, A. C.; Leslie, L. A.; Tun, H. W.; Lunning, M. A.; Isufi, I.; Martell, R.; Patel, K.
Blood (2019)

Fulltext@MSK | Save

Evolution in practice patterns and differences among experts and community healthcare providers in the treatment of patients with chronic lymphocytic leukemia

Meeting Abstract

Xu, B. E.; Rosenthal, K. M.; Marcello, K.; Awan, F. T.; Coutre, S.; Lamanna, N.; Sharman, J. P.; Quill, T. A.; Obholz, K. L.; Zelenetz, A. D.
Blood (2019)

Fulltext@MSK | Save

A prospective disease registry of patients with mantle cell lymphoma treated with novel agents: Treatment patterns, outcomes, and patient-reported health-related quality of life

Meeting Abstract

Ujjani, C.; Mato, A. R.; Cohen, J. B.; Svoboda, J.; Andorsky, D.; Goy, A.; Wang, M. L.; Kumar, A.; Torney, P. A.; Dawson, M.; more...
Blood (2019)

Fulltext@MSK | Save

Veneto-STOP study: Sequential assessment of minimal residual disease by next generation sequencing to optimize outcomes and minimize exposure in venetoclax-treated CLL patients

Meeting Abstract

Ujjani, C. S.; Roeker, L. E.; Shadman, M.; Whitaker, K. J.; Jacob, A. P.; Geyer, M. B.; Dorsey, C.; Zelenetz, A. D.; Mato, A. R.
Blood (2019)

Fulltext@MSK | Save

Current selection patterns, toxicities and outcomes of pre-transplant salvage treatment regimens in patients with relapsed/refractory Hodgkin lymphoma: Results of a multicenter retrospective analysis

Meeting Abstract

Svoboda, J.; Ballard, H. J.; Bair, S. M.; Banerjee, R.; Andreadis, C.; Feldman, T. A.; McCarthy, E. L.; Khan, N.; Moskowitz, A. J.; Orellana-Noia, V. M.; more...
Blood (2019)

Fulltext@MSK | Save

A multicenter, open-label feasibility study of daratumumab with dose-adjusted EPOCH in newly diagnosed plasmablastic lymphoma: AIDS Malignancy Consortium 105

Meeting Abstract

Tan, C. R.; Barta, S. K.; Lensing, S. Y.; Noy, A.
Blood (2019)

Fulltext@MSK | Save

Rapid and durable responses with the SYK/JAK inhibitor cerdulatinib in a phase 2 study in relapsed/refractory follicular lymphoma-alone or in combination with rituximab

Meeting Abstract

Smith, S. D.; Munoz, J.; Stevens, D.; Smith, S. M.; Feldman, T. A.; Ye, J. C.; de Vos, S.; Hess, B. T.; Miller, C. B.; Khatcheressian, J. L.; more...
Blood (2019)

Fulltext@MSK | Save

Comparative analysis of immune reconstitution in HIV-positive recipients of allogeneic and autologous stem cell transplant on the BMT CTN 0903/AMC-080 and BMT CTN 0803/AMC-071 trials

Meeting Abstract

Shindiapina, P.; Pietrzak, M.; Seweryn, M.; McLaughlin, E.; Zhang, X.; Makowski, M.; Lyberger, J.; Chang, H.; Ahmed, E. H.; Prouty, A.; more...
Blood (2019)

Fulltext@MSK | Save